Skip to main navigation Skip to search Skip to main content

Tissue Effects after Stereotactic Body Radiotherapy using Cyberknife for Patients with Abdominal Malignancies

  • J. S. Cupp
  • , A. C. Koong
  • , G. A. Fisher
  • , J. A. Norton
  • , K. A. Goodman

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: To report the tissue effects of treatment with single fraction stereotactic body radiotherapy (SBRT) using Cyberknife on malignant tumours of the abdomen and adjacent normal organs. Materials and methods: The data from four autopsies with unresectable pancreatic carcinoma and one lymph node excision from a case of recurrent neuroblastoma were reviewed for radiation-related tissue effects within the primary cancer and the normal organs within the radiation field. Results: Cases of unresectable pancreatic carcinoma consistently showed radiation-induced changes in both the primary tumour and the adjacent, non-malignant colorectal tissue. An additional case of lymph nodes exposed to stereotactic radiation showed typical radiation-related changes, including lymphocyte depletion and capsular fibrosis. Conclusions: A myriad of radiation-related tissue effects are seen after SBRT with Cyberknife. The changes parallel those reported after conventionally fractionated radiotherapy and suggest that the pathophysiological mechanisms of radiation-induced normal tissue damage are similar for biologically equivalent single and fractionated doses of radiotherapy.

Original languageEnglish (US)
Pages (from-to)69-75
Number of pages7
JournalClinical Oncology
Volume20
Issue number1
DOIs
StatePublished - Feb 1 2008

Keywords

  • Cyberknife
  • neuroblastoma
  • pancreatic carcinoma
  • stereotactic body radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Tissue Effects after Stereotactic Body Radiotherapy using Cyberknife for Patients with Abdominal Malignancies'. Together they form a unique fingerprint.

Cite this